Tamar Securities, LLC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
Tamar Securities, LLC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$513,360
+18.6%
53,4750.0%0.16%
+17.3%
Q3 2022$433,000
+43.4%
53,4750.0%0.14%
+40.4%
Q2 2022$302,000
+1.0%
53,4750.0%0.10%
+19.3%
Q1 2022$299,000
+27.2%
53,4750.0%0.08%
+20.3%
Q4 2021$235,00053,4750.07%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders